Regardless of the macroeconomic environment, we remain focused on applying our well-established, long-term, bottom-up EQV ...

The hope is that a U.K. deal will provide a template for further arrangements that can bring overall tariffs down to minimal ...

The medicine, Trastuzumab deruxtecan, was already available for some breast and stomach cancers. It has been approved to ...

ACTO, the AI-powered Intelligent Field Excellence (IFE) platform built specifically for life sciences, today announced the ...

Breztri Aerosphere, a triple inhaled therapy, met its primary endpoint of lung function improvement in adults and adolescents with uncontrolled asthma in two phase 3 trials, according to a press ...

The UK sells around 200,000 tonnes of steel a year to the US, worth over £400m. Britain’s aluminium sector has also warned of ...

Larry Hogan speaks to members of the media at the AstraZeneca facility in Gaithersburg, Md., on Aug. 26, 2024. Larry Hogan ...

"Portugal is very attractive for staff and in terms of talent" - Nathalie von Widdern, country president, AstraZeneca.

Two new RCTs of rituximab will soon begin in the United Kingdom: A biomarker-based trial with add-on belimumab and another in ...

AstraZeneca and Daiichi's Enhertu, followed by THP, has shown pCR rate improvement in the randomised DESTINY-Breast11 Phase ...

The AstraZeneca share price has pulled back in recent months. Dr James Fox explores how the stock compares with pharma peer GSK. The post Does the GSK or AstraZeneca share price currently offer the ...

AstraZeneca (AZN) and Daiichi Sankyo (DSNKY) announce that Enhertu hit the main goal in a Phase 3 trial for early-stage ...